DEC 05, 2017 11:39 AM PST

Scientists Finally Figure Out How Immune Cells Release IL-1

WRITTEN BY: Kara Marker

A signaling molecule called IL-1 was identified for the first time in 1984, and only now are scientists fully understanding how cells release it. From Boston Children’s Hospital, researchers describe the protein responsible for releasing IL-1 from immune cells.

Living macrophages releasing IL-1. The bright green spots are large protein complexes that stimulate gasdermin D to form pores allowing IL-1 to pass through. Credit: Charles Evavold, Boston Children's Hospital

Until now, scientists theorized that perhaps IL-1 wasn’t actively released by cells at all, that instead it was just “passively released from dead cells.” But IL-1 is indeed actively released by cells, thanks to a protein called gasdermin D. Why did it take so long to learn this about IL-1? "Most proteins have a secretion signal that causes them to leave the cell," explained senior author Jonathan Kagan, PhD. "IL-1 doesn't have that signal.”

Gasdermin D facilitates the release of IL-1 by poking holes in the cell membrane during an infection. Past studies showed gasdermin D triggering the release of other cytokines through a similar process called pyroptosis where the cell dies during the cytokine’s release. But sometimes, in the case of IL-1 release, the cell doesn’t have to die.

In 2016, some of the present study’s authors found that when dendritic cells release IL-1, they shift into a hyperactivated state, and their ability to recruit memory T cells enhances. Dendritic cells are antigen-presenting cells, which means they take pieces of foreign particles, potentially pathogens, and present them to T cells, which decide whether or not to launch an attack. In the new study, researchers experimented with hyperactivated macrophages, phagocytic cells that engulf and digest pathogens.

The new experiments showed that macrophages could also release IL-1 without dying. “Gasdermin forms enough pores to let IL-1 pass through, but not enough to kill the cell," Kagan explained.

In light of the results connecting immune cells, gastrodermin D, and the release of IL-1, boosting IL-1 release from live immune cells could be a new approach to increasing memory T cell levels. These are cells that “remember” past pathogens and are at the ready to target them again should the pathogen return.

This approach wouldn’t come without its risks, though. Researchers would have to be careful because too many inflammatory cells, a result of higher IL-1 release, can lead to autoimmune diseases; IL-1 is often a drug target for Alzheimer’s disease and inflammatory disorders.

The present study was published in the journal Immunity.

Sources: Immunology and Cell Biology, Boston Children’s Hospital

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 12, 2021
Health & Medicine
Atopic Dermatitis: A Harbinger of Autoimmune Diseases?
OCT 12, 2021
Atopic Dermatitis: A Harbinger of Autoimmune Diseases?
New research published in Allergy, Asthma & Clinical Immunology found an increased risk of autoimmune disease develo ...
NOV 02, 2021
Immunology
Green Tea Isn't an Antioxidant After All (But It's Still Good for You)
NOV 02, 2021
Green Tea Isn't an Antioxidant After All (But It's Still Good for You)
Green tea has long been touted as the elixir of youth—high concentrations of chemicals called polyphenols were bel ...
NOV 04, 2021
Cancer
Giving the Immune System a Kickstart to Improve Immunotherapy Efficacy
NOV 04, 2021
Giving the Immune System a Kickstart to Improve Immunotherapy Efficacy
Despite the incremental success immune checkpoint inhibitors (ICI) have attributed to the cancer treatment landscape rec ...
NOV 17, 2021
Microbiology
Large Flu Outbreak at the University of Michigan Draws CDC's Attention
NOV 17, 2021
Large Flu Outbreak at the University of Michigan Draws CDC's Attention
Every year, there is a flu outbreak, and the severity can depend on many factors, like what strain is circulating. Last ...
JAN 07, 2022
Cancer
Crossing the Blood-Brain Barrier: Improving Experimental Models to Study Drug Delivery
JAN 07, 2022
Crossing the Blood-Brain Barrier: Improving Experimental Models to Study Drug Delivery
The blood-brain barrier (BBB) describes the complex vasculature network that delivers oxygen and nutrients to the brain. ...
JAN 14, 2022
Drug Discovery & Development
Repurposing Drugs 101
JAN 14, 2022
Repurposing Drugs 101
Drug development is expensive. Taking into account costs of failed trials, the average drug costs $985 million to resear ...
Loading Comments...